The Pharmacokinetics of Beclabuvir (BMS-791325) When Administered in Combination With Daclatasvir and Asunaprevir in Treatment-naive Patients With or Without Cirrhosis Infected With HCV Genotype 1
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
He B, Sims K, Chung E, Luo W-L, Pursley J, Wind-Rotolo M, LaCreta F, Bertz R, AbuTarif M
Bristol-Myers Squibb Research and Development, Princeton, NJ, USA
